MFDS
- Marketing authorisation holder: ALKEM LABS LTD
- Status: likely_approved
🇰🇷 Eslicarbazepine Acetate in South Korea
Eslicarbazepine Acetate (ESLICARBAZEPINE) regulatory status in South Korea.
Marketing authorisation
Eslicarbazepine Acetate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Eslicarbazepine Acetate approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Eslicarbazepine Acetate in South Korea?
ALKEM LABS LTD holds the South Korean marketing authorisation.